Alector, Inc. (ALEC)
NASDAQ: ALEC · Real-Time Price · USD
2.320
-0.060 (-2.52%)
Mar 11, 2026, 4:00 PM EDT - Market closed
Alector Market Cap
Alector has a market cap or net worth of $256.04 million as of March 11, 2026. Its market cap has increased by 46.88% in one year.
Market Cap
256.04M
Enterprise Value
34.04M
1-Year Change
46.88%
Ranking
Category
Stock Price
$2.32
Market Cap Chart
Since February 7, 2019, Alector's market cap has decreased from $1.23B to $256.04M, a decrease of -79.19%. That is a compound annual growth rate of -19.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 262.66M | 54.26% |
| Dec 31, 2025 | 170.28M | -8.00% |
| Dec 31, 2024 | 185.09M | -72.43% |
| Dec 29, 2023 | 671.41M | -12.04% |
| Dec 30, 2022 | 763.34M | -54.52% |
| Dec 31, 2021 | 1.68B | 39.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prelude Therapeutics | 254.61M |
| Surrozen | 252.55M |
| Cibus | 248.61M |
| Nuvectis Pharma | 240.54M |
| Cartesian Therapeutics | 239.11M |
| Sol-Gel Technologies | 236.76M |
| Protalix BioTherapeutics | 231.61M |
| Humacyte | 231.60M |